|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shah S, Haddad R and Al-Sukhni W: Surgical
resection of hepatic and pulmonary metastases from colorectal
carcinoma. J Am Coll Surg. 202:468–475. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Safi F and Beyer HG: The value of
follow-up after curative surgery of colorectal carcinoma. Cancer
Detect Prev. 17:417–424. 1993.PubMed/NCBI
|
|
4
|
André T, Boni C, Navarro M, et al:
Improved overall survival with oxaliplatin, fluorouracil, and
leucovorin as adjuvant treatment in stage II or III colon cancer in
the MOSAIC trial. J Clin Oncol. 27:3109–3016. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allard WJ, Matera J, Miller MC, et al:
Tumor cells circulate in the peripheral blood of all major
carcinomas but not in healthy subjects or patients with
nonmalignant diseases. Clin Cancer Res. 10:6897–6904. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cristofanilli M and Budd G: Circulating
tumor cells, disease progression, and survival in metastatic breast
cancer. Engl J Med. 351:781–791. 2004. View Article : Google Scholar
|
|
7
|
De Bono JS, Scher HI, Montgomery RB, et
al: Circulating tumor cells predict survival benefit from treatment
in metastatic castration-resistant prostate cancer. Clin Cancer
Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cohen SJ, Punt CJA, Iannotti N, et al:
Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Franken B, de Groot MR, Mastboom WJB,
Vermes I, van der Palen J, Tibbe AGJ and Terstappen LWMM:
Circulating tumor cells, disease recurrence and survival in newly
diagnosed breast cancer. Breast Cancer Res. 14:R1332012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Dalum G, van der Stam GJ, Tibbe AGJ,
et al: Circulating tumor cells before and during follow-up after
breast cancer surgery. Int J Oncol. 46:407–413. 2015.
|
|
11
|
Liu MC, Shields PG, Warren RD, et al:
Circulating tumor cells: a useful predictor of treatment efficacy
in metastatic breast cancer. J Clin Oncol. 27:5153–5159. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pierga JY, Hajage D, Bachelot T, et al:
High independent prognostic and predictive value of circulating
tumor cells compared with serum tumor markers in a large
prospective trial in first-line chemotherapy for metastatic breast
cancer patients. Ann Oncol. 23:618–624. 2012. View Article : Google Scholar
|
|
13
|
Tol J, Koopman M, Miller MC, et al:
Circulating tumour cells early predict progression-free and overall
survival in advanced colorectal cancer patients treated with
chemotherapy and targeted agents. Ann Oncol. 21:1006–1012. 2010.
View Article : Google Scholar
|
|
14
|
Lucci A, Hall CS, Lodhi AK, et al:
Circulating tumour cells in non-metastatic breast cancer: a
prospective study. Lancet Oncol. 13:688–695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bidard FC, Mathiot C, Delaloge S, et al:
Single circulating tumor cell detection and overall survival in
non-metastatic breast cancer. Ann Oncol. 21:729–733. 2010.
View Article : Google Scholar
|
|
16
|
Martín M, Custodio S, de Las Casas MLM, et
al: Circulating tumor cells following first chemotherapy cycle: an
early and strong predictor of outcome in patients with metastatic
breast cancer. Oncologist. 18:917–923. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
https://www.oncoline.nl. Integr
Kankercent Ned. 2013
|
|
18
|
R Core Team. R: A Language and Environment
for Statistical Computing. 2013
|
|
19
|
Jueckstock JK, Rack BK, Zwingers T, Hepp
PGM, Schneeweiss A, Beckmann MW, Lichtenegger W, Sommer HL, Pantel
K, Tesch H, Forstbauer H, Lorenz R, Rezai M, Neugebauer JK,
Andergassen U, Friese K and Janni W: Prognostic relevance of
circulating tumor cells (CTC) before adjuvant chemotherapy in
patients with breast cancer: results of the German SUCCESS trial. J
Clin Oncol. 29(Suppl): 10332011.
|
|
20
|
Pierga JY, Bidard FC, Mathiot C, et al:
Circulating tumor cell detection predicts early metastatic relapse
after neoadjuvant chemotherapy in large operable and locally
advanced breast cancer in a phase II randomized trial. Clin Cancer
Res. 14:7004–7010. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coumans FA, Siesling S and Terstappen LW:
Detection of cancer before distant metastasis. BMC Cancer.
13:2832013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cohen SJ, Punt CJ, Iannotti N, et al:
Prognostic significance of circulating tumor cells in patients with
metastatic colorectal cancer. Ann Oncol. 20:1223–1229. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tibbe AGJ, Miller MC and Terstappen LWMM:
Statistical considerations for enumeration of circulating tumor
cells. Cytometry A. 71:154–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thorsteinsson M, Soletormos G and Jess P:
Low number of detectable circulating tumor cells in non-metastatic
colon cancer. Anticancer Res. 31:613–617. 2011.PubMed/NCBI
|
|
25
|
Sastre J, Maestro ML, Puente J, et al:
Circulating tumor cells in colorectal cancer: correlation with
clinical and pathological variables. Ann Oncol. 19:935–938. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hiraiwa K, Takeuchi H, Hasegawa H, et al:
Clinical significance of circulating tumor cells in blood from
patients with gastrointestinal cancers. Ann Surg Oncol.
15:3092–3100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gazzaniga P, Gianni W and Raimondi C:
Circulating tumor cells in high-risk nonmetastatic colorectal
cancer. Tumor Biol. 34:2507–2509. 2013. View Article : Google Scholar
|
|
28
|
Coumans FA, Ligthart ST, Uhr JW and
Terstappen LWMM: Challenges in the enumeration and phenotyping of
CTC. Clin Cancer Res. 18:5711–5718. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pantel K, Denève E, Nocca D, et al:
Circulating epithelial cells in patients with benign colon
diseases. Clin Chem. 58:936–940. 2012. View Article : Google Scholar
|
|
30
|
Wind J, Tuynman JB, Tibbe AG, Swennenhuis
JF, Richel DJ, van Berge Henegouwen MI and Bemelman WA: Circulating
tumour cells during laparoscopic and open surgery for primary
colonic cancer in portal and peripheral blood. Eur J Surg Oncol.
35:942–950. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bednarz-Knoll N, Alix-Panabières C and
Pantel K: Clinical relevance and biology of circulating tumor
cells. Breast Cancer Res. 13:2282011. View
Article : Google Scholar : PubMed/NCBI
|
